Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-01 Tax Withholding | 2023-02-03 5:02 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 36 | $3.52 | 20,294 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:02 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 12,000 | $0 | 20,294 (Direct) | View |
| 2023-02-01 Option Award | 2023-02-03 5:02 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 1,000 | $3.52 | 20,294 (Direct) | View |
| 2022-09-01 Tax Withholding | 2022-09-06 4:55 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 570 | $8.53 | 7,330 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:35 pm | N/A 2032-01-31 | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 5,000 | $0 | 12,900 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-03 4:35 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 400 | $10.02 | 12,900 (Direct) | View |
Ownership | 2021-09-02 6:39 pm | N/A N/A | LUMOS PHARMA INC. | LUMO | Karpf David B Chief Medical Officer | 0 | $0 | 50,000 (Direct) | View |